Clinical Trial Update: RAS Quantification in Patients With Aliskiren or Candesartan [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing renin-angiotensin system quantification in patients with hypertension or chronic kidney disease treated with aliskiren o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension
• Proteinuria

Drugs mentioned

• Atacand (candesartan)
• Tekturna (aliskiren)

Snippet

Sponsor: Medical University of Vienna | Conditions: Hypertension, Chronic Kidney Disease | Phase 4 | Status: COMPLETED